Know the Facts about Coronavirus Disease 2019 (COVID-19)

Condition | Cardiology


  • Contact Name: Center for Clinical Research
  • Status: Active / Closed to Enrollment
  • Phone: 585.922.3536
  • Lead Researcher: Gerald Gacioch, MD


Study of post-myocardial infarction (heart attack) drug to prevent future cardiovascular events using interleukin anti-body to reduce cardiovascular inflammation

Sponsor: Novartis Pharmaceutical

Keywords: MI, myocardial infarction, heart attack, heart disease, heart, cardiac, canakinumab, Novartis, Cantos, anti-inflammatory, drug, cardiovascular